Amplo Biotechnology
Amplo is developing gene therapies (AAV) for diseases affecting the neuromuscular junction (e.g.
DeepWEBSITE ↗
Why it's on the radar
TeamFundraising signals (who's likely raising, and why) are on Team.Start a free 14-day trial →Funding history · 0 rounds
No rounds on record yet.
Key people
ProKey people, exec moves and open roles are on Pro.Start a free 14-day trial →